Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Lancet Oncol. 2015 Jun 9;16(7):775–786. doi: 10.1016/S1470-2045(15)00047-9

Figure 3.

Figure 3

Vaccine efficacy for individual HPV types by dose, for incident HPV infections that were detected one time (panel A), that persisted 6+ months (panel B), and that persisted 12+ months (panel C) (M-TVC).